Comparative LDL-C Lowering Efficacy of Nonstatin Therapies: Inclisiran Is Better Than Ezetimibe, PCSK9 Inhibitors, and Bempedoic Acid

非他汀类药物降低低密度脂蛋白胆固醇（LDL-C）疗效的比较：因克立西兰优于依泽替米贝、PCSK9抑制剂和贝培多酸。